23.12.2020 04:05:44
|
Walmart Accused Of Fueling Opioid Crisis In U.S.
(RTTNews) - The U.S. Department of Justice filed a lawsuit against Walmart alleging that the company unlawfully dispensed controlled substances through its pharmacies and fueled the opioid crisis. It seeks civil penalties that could total in the billions of dollars.
Responding to the lawsuit, Walmart said that the Justice Department's investigation is tainted by historical ethics violations, and the lawsuit invents a legal theory that unlawfully forces pharmacists to come between patients and their doctors.
Walmart also alleged that the lawsuit is riddled with factual inaccuracies and cherry-picked documents taken out of context.
The Justice Department's complaint, which was filed in the U.S. District Court for the District of Delaware, alleged that as the operator of its pharmacies, Walmart knowingly filled thousands of controlled substance prescriptions that were not issued for legitimate medical purposes or in the usual course of medical practice, and that it filled prescriptions outside the ordinary course of pharmacy practice.
The complaint also alleged that as the operator of its distribution centers, Walmart received hundreds of thousands of suspicious orders that it failed to report as required to by the U.S. Drug Enforcement Administration.
Therefore, the complaint said that the unlawful conduct resulted in hundreds of thousands of violations of the Controlled Substances Act. It seeks civil penalties, which could total in the billions of dollars, and injunctive relief.
If Walmart is found liable for violating the rule, it could face civil penalties of up to $67,627 for each unlawful prescription filled and $15,691 for each suspicious order not reported. The court also may award injunctive relief to prevent Walmart from committing further violations of the Controlled Substances Act.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Walmartmehr Nachrichten
17.01.25 |
US sues Pepsi over discounts to Walmart at expense of smaller rivals (Financial Times) | |
17.01.25 |
US sues Pepsi over discounts to Walmart at expense of smaller rivals (Financial Times) | |
16.01.25 |
Symbotic-Aktie legt zweistellig zu: Übernahme von Walmart-Geschäftsbereich begeistert Anleger (finanzen.at) | |
16.01.25 |
Schwache Performance in New York: Dow Jones startet mit Verlusten (finanzen.at) | |
15.01.25 |
Dow Jones 30 Industrial-Titel Walmart-Aktie: So viel Gewinn hätte ein Walmart-Investment von vor 3 Jahren eingefahren (finanzen.at) | |
13.01.25 |
Freundlicher Handel in New York: Dow Jones bewegt sich zum Handelsende im Plus (finanzen.at) | |
13.01.25 |
Freundlicher Handel: Dow Jones präsentiert sich nachmittags fester (finanzen.at) | |
13.01.25 |
Optimismus in New York: Dow Jones verbucht mittags Zuschläge (finanzen.at) |
Analysen zu Walmartmehr Analysen
05.12.24 | Walmart Buy | UBS AG | |
20.11.24 | Walmart Halten | DZ BANK | |
20.11.24 | Walmart Buy | Goldman Sachs Group Inc. | |
20.11.24 | Walmart Buy | Jefferies & Company Inc. | |
20.11.24 | Walmart Buy | UBS AG |
Aktien in diesem Artikel
Walmart | 89,42 | 0,85% |